首页 > 最新文献

The Lancet Diabetes & Endocrinology最新文献

英文 中文
A new dawn for osteoporosis drug development 骨质疏松药物开发的新曙光
IF 44.5 1区 医学 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2026-02-05 DOI: 10.1016/s2213-8587(26)00011-2
{"title":"A new dawn for osteoporosis drug development","authors":"","doi":"10.1016/s2213-8587(26)00011-2","DOIUrl":"https://doi.org/10.1016/s2213-8587(26)00011-2","url":null,"abstract":"","PeriodicalId":48790,"journal":{"name":"The Lancet Diabetes & Endocrinology","volume":"30 1","pages":""},"PeriodicalIF":44.5,"publicationDate":"2026-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146134077","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Aligning diabetes surveillance with clinical reality. 将糖尿病监测与临床实际相结合。
IF 41.8 1区 医学 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2026-02-01 Epub Date: 2025-12-23 DOI: 10.1016/S2213-8587(25)00404-8
The Lancet Diabetes Endocrinology
{"title":"Aligning diabetes surveillance with clinical reality.","authors":"The Lancet Diabetes Endocrinology","doi":"10.1016/S2213-8587(25)00404-8","DOIUrl":"10.1016/S2213-8587(25)00404-8","url":null,"abstract":"","PeriodicalId":48790,"journal":{"name":"The Lancet Diabetes & Endocrinology","volume":" ","pages":"93"},"PeriodicalIF":41.8,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145844397","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
3 months of romosozumab: a pragmatic clinical solution 3个月的romosozumab:一个实用的临床解决方案
IF 44.5 1区 医学 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2026-01-29 DOI: 10.1016/s2213-8587(25)00323-7
Sundeep Khosla
{"title":"3 months of romosozumab: a pragmatic clinical solution","authors":"Sundeep Khosla","doi":"10.1016/s2213-8587(25)00323-7","DOIUrl":"https://doi.org/10.1016/s2213-8587(25)00323-7","url":null,"abstract":"","PeriodicalId":48790,"journal":{"name":"The Lancet Diabetes & Endocrinology","volume":"93 1","pages":""},"PeriodicalIF":44.5,"publicationDate":"2026-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146072229","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
3 months vs 12 months of romosozumab for postmenopausal osteoporosis (LIDA): an open-label, non-inferiority, randomised controlled trial 3个月vs 12个月的罗莫索单抗治疗绝经后骨质疏松症(LIDA):一项开放标签、非劣效性、随机对照试验
IF 44.5 1区 医学 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2026-01-29 DOI: 10.1016/s2213-8587(25)00319-5
Benjamin Z Leder, Sabashini K Ramchand, Mackenzie Jordan, Savannah Ryan, Aparna Patnaik, Hang Lee, Joy N Tsai
{"title":"3 months vs 12 months of romosozumab for postmenopausal osteoporosis (LIDA): an open-label, non-inferiority, randomised controlled trial","authors":"Benjamin Z Leder, Sabashini K Ramchand, Mackenzie Jordan, Savannah Ryan, Aparna Patnaik, Hang Lee, Joy N Tsai","doi":"10.1016/s2213-8587(25)00319-5","DOIUrl":"https://doi.org/10.1016/s2213-8587(25)00319-5","url":null,"abstract":"","PeriodicalId":48790,"journal":{"name":"The Lancet Diabetes & Endocrinology","volume":"2 1","pages":""},"PeriodicalIF":44.5,"publicationDate":"2026-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146071687","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Country-level implementation of Europe's Safe Hearts Plan for cardiovascular health 在国家一级实施欧洲心血管健康安全心脏计划
IF 44.5 1区 医学 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2026-01-29 DOI: 10.1016/s2213-8587(26)00004-5
Stefano Del Prato, Francesco Giorgino, Bart Torbeyns, Jennifer L Sargent, Kasia Karpinska, Chantal Mathieu
{"title":"Country-level implementation of Europe's Safe Hearts Plan for cardiovascular health","authors":"Stefano Del Prato, Francesco Giorgino, Bart Torbeyns, Jennifer L Sargent, Kasia Karpinska, Chantal Mathieu","doi":"10.1016/s2213-8587(26)00004-5","DOIUrl":"https://doi.org/10.1016/s2213-8587(26)00004-5","url":null,"abstract":"","PeriodicalId":48790,"journal":{"name":"The Lancet Diabetes & Endocrinology","volume":"8 1","pages":""},"PeriodicalIF":44.5,"publicationDate":"2026-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146072230","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Menopausal hormone treatment and breast cancer 更年期激素治疗和乳腺癌
IF 44.5 1区 医学 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2026-01-28 DOI: 10.1016/s2213-8587(25)00394-8
Anne Gompel, Richard Simcock
{"title":"Menopausal hormone treatment and breast cancer","authors":"Anne Gompel, Richard Simcock","doi":"10.1016/s2213-8587(25)00394-8","DOIUrl":"https://doi.org/10.1016/s2213-8587(25)00394-8","url":null,"abstract":"","PeriodicalId":48790,"journal":{"name":"The Lancet Diabetes & Endocrinology","volume":"17 1","pages":""},"PeriodicalIF":44.5,"publicationDate":"2026-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146072233","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gene-environment interactions underlying temporal trends in type 2 diabetes prevalence 基因-环境相互作用是2型糖尿病流行的时间趋势
IF 44.5 1区 医学 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2026-01-28 DOI: 10.1016/s2213-8587(25)00355-9
Tiange Wang
{"title":"Gene-environment interactions underlying temporal trends in type 2 diabetes prevalence","authors":"Tiange Wang","doi":"10.1016/s2213-8587(25)00355-9","DOIUrl":"https://doi.org/10.1016/s2213-8587(25)00355-9","url":null,"abstract":"","PeriodicalId":48790,"journal":{"name":"The Lancet Diabetes & Endocrinology","volume":"74 1","pages":""},"PeriodicalIF":44.5,"publicationDate":"2026-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146072232","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Temporal changes and genetic susceptibility to type 2 diabetes (1984–2019; HUNT): a longitudinal, population-based study 时间变化和2型糖尿病的遗传易感性(1984-2019;HUNT):一项基于人群的纵向研究
IF 44.5 1区 医学 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2026-01-28 DOI: 10.1016/s2213-8587(25)00322-5
Vera Vik Bjarkø, Brooke N Wolford, Eirin B Haug, Lars C Stene, Sofia Carlsson, Arnulf Langhammer, Kåre I Birkeland, Tore Julsrud Berg, Elin Pettersen Sørgjerd, Valeriya Lyssenko, Ben M Brumpton, Gunnhild Åberge Vie, Bjørn Olav Åsvold
{"title":"Temporal changes and genetic susceptibility to type 2 diabetes (1984–2019; HUNT): a longitudinal, population-based study","authors":"Vera Vik Bjarkø, Brooke N Wolford, Eirin B Haug, Lars C Stene, Sofia Carlsson, Arnulf Langhammer, Kåre I Birkeland, Tore Julsrud Berg, Elin Pettersen Sørgjerd, Valeriya Lyssenko, Ben M Brumpton, Gunnhild Åberge Vie, Bjørn Olav Åsvold","doi":"10.1016/s2213-8587(25)00322-5","DOIUrl":"https://doi.org/10.1016/s2213-8587(25)00322-5","url":null,"abstract":"","PeriodicalId":48790,"journal":{"name":"The Lancet Diabetes & Endocrinology","volume":"44 1","pages":""},"PeriodicalIF":44.5,"publicationDate":"2026-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146072231","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy and safety of inclisiran in adolescents with heterozygous familial hypercholesterolaemia (ORION-16): a two-part, randomised, multicentre clinical trial inclisiran治疗青少年杂合性家族性高胆固醇血症(ORION-16)的疗效和安全性:一项两部分、随机、多中心临床试验
IF 44.5 1区 医学 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2026-01-27 DOI: 10.1016/s2213-8587(25)00351-1
Albert Wiegman, Amy L Peterson, Eric Bruckert, Joep C Defesche, Anja Schweizer, Jean Bergeron, María J Chueca, Jeanine E Roeters van Lennep, Raul D Santos, Karl Otfried Schwab, Anastasia Lesogor, Sijia Zhang, Robert A Hegele
{"title":"Efficacy and safety of inclisiran in adolescents with heterozygous familial hypercholesterolaemia (ORION-16): a two-part, randomised, multicentre clinical trial","authors":"Albert Wiegman, Amy L Peterson, Eric Bruckert, Joep C Defesche, Anja Schweizer, Jean Bergeron, María J Chueca, Jeanine E Roeters van Lennep, Raul D Santos, Karl Otfried Schwab, Anastasia Lesogor, Sijia Zhang, Robert A Hegele","doi":"10.1016/s2213-8587(25)00351-1","DOIUrl":"https://doi.org/10.1016/s2213-8587(25)00351-1","url":null,"abstract":"","PeriodicalId":48790,"journal":{"name":"The Lancet Diabetes & Endocrinology","volume":"2 1","pages":""},"PeriodicalIF":44.5,"publicationDate":"2026-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146072235","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Inclisiran for children: is it worth it? 儿童用Inclisiran:值得吗?
IF 44.5 1区 医学 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2026-01-27 DOI: 10.1016/s2213-8587(25)00367-5
Lluís Masana, Daiana Ibarretxe
{"title":"Inclisiran for children: is it worth it?","authors":"Lluís Masana, Daiana Ibarretxe","doi":"10.1016/s2213-8587(25)00367-5","DOIUrl":"https://doi.org/10.1016/s2213-8587(25)00367-5","url":null,"abstract":"","PeriodicalId":48790,"journal":{"name":"The Lancet Diabetes & Endocrinology","volume":"66 1","pages":""},"PeriodicalIF":44.5,"publicationDate":"2026-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146072234","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
The Lancet Diabetes & Endocrinology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1